Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 13, 2013 - Issue 4
Submit an article Journal homepage
203
Views
12
CrossRef citations to date
0
Altmetric
Theme: Gastrointestinal & Hepatopancreatobiliary Cancer - Review

Emerging role of stereotactic body radiotherapy in the treatment of pancreatic cancer

Betul Berber Department of Surgery, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH, USA; Department of Surgery, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH, USA
,
Juan R Sanabria Department of Surgery, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH, USA; Department of Surgery, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH, USA
,
Kelly Braun Robert Wood Johnson Medical School, New Brunswick, NJ, USA; Robert Wood Johnson Medical School, New Brunswick, NJ, USA
,
Min Yao Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA
,
Rodney J Ellis Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA
,
Charles A Kunos Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA
,
Jason Sohn Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA
,
Mitchell Machtay Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA
,
Bin S Teh Department of Radiation Oncology, The Methodist Cancer Center, Houston, TX, USA; Department of Radiation Oncology, The Methodist Cancer Center, Houston, TX, USA
,
Zhibin Huang Department of Radiation Oncology, East Carolina University, Greenville, NC, USA; Department of Radiation Oncology, East Carolina University, Greenville, NC, USA
,
Nina A Mayr Department of Radiation Oncology, Arthur G. James Cancer Hospital, The Ohio State University, Columbus, OH, USA; Department of Radiation Oncology, Arthur G. James Cancer Hospital, The Ohio State University, Columbus, OH, USA
&
Simon S Lo Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA. [email protected]; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH, USA. [email protected]
 show all
Pages 481-487 | Published online: 10 Jan 2014

References

  • Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA. Cancer J. Clin. 62(1), 10–29 (2012).
  • Tseng JF, Raut CP, Lee JE et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J. Gastrointest. Surg. 8(8), 935–949; discussion 949 (2004).
  • Hoyer M, Roed H, Sengelov L et al. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. Radiother. Oncol. 76(1), 48–53 (2005).
  • Regine WF, Winter KA, Abrams R et al. Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 Phase III trial. Ann. Surg. Oncol. 18(5), 1319–1326 (2011).
  • Chang BW, Saif MW. Stereotactic body radiation therapy (SBRT) in pancreatic cancer: is it ready for prime time? JOP 9(6), 676–682 (2008).
  • Koong AC, Le QT, Ho A et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 58(4), 1017–1021 (2004).
  • Krishnan S, Rana V, Janjan NA et al. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy. Cancer 110(1), 47–55 (2007).
  • Gastrointestinal Tumor Study Group. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J. Natl Cancer Inst. 80(10), 751–755 (1988).
  • Johung K, Saif MW, Chang BW. Treatment of locally advanced pancreatic cancer: the role of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 82(2), 508–518 (2012).
  • Willett CG, Czito BG, Bendell JC, Ryan DP. Locally advanced pancreatic cancer. J. Clin. Oncol. 23(20), 4538–4544 (2005).
  • Winter JM, Cameron JL, Campbell KA et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J. Gastrointest. Surg. 10(9), 1199–1210; discussion 1210 (2006).
  • Campbell F, Smith RA, Whelan P et al. Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin. Histopathology 55(3), 277–283 (2009).
  • Gillen S, Schuster T, Friess H, Kleeff J. Palliative resections versus palliative bypass procedures in pancreatic cancer – a systematic review. Am. J. Surg. 203(4), 496–502 (2012).
  • Mishra G, Butler J, Ho C et al. Phase II trial of induction gemcitabine/CPT-11 followed by a twice-weekly infusion of gemcitabine and concurrent external beam radiation for the treatment of locally advanced pancreatic cancer. Am. J. Clin. Oncol. 28(4), 345–350 (2005).
  • Mahadevan A, Jain S, Goldstein M et al. Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 78(3), 735–742 (2010).
  • El-Rayes BF, Zalupski MM, Shields AF et al. Phase II study of gemcitabine, cisplatin, and infusional fluorouracil in advanced pancreatic cancer. J. Clin. Oncol. 21(15), 2920–2925 (2003).
  • Louvet C, André T, Lledo G et al. Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter Phase II study. J. Clin. Oncol. 20(6), 1512–1518 (2002).
  • Louvet C, Labianca R, Hammel P et al.; GERCOR; GISCAD. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD Phase III trial. J. Clin. Oncol. 23(15), 3509–3516 (2005).
  • Loehrer PJ Sr, Feng Y, Cardenes H et al. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J. Clin. Oncol. 29(31), 4105–4112 (2011).
  • Wilkowski R, Boeck S, Ostermaier S et al. Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer – a multi-centre randomised Phase II study. Br. J. Cancer 101(11), 1853–1859 (2009).
  • Crane CH, Winter K, Regine WF et al. Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411. J. Clin. Oncol. 27(25), 4096–4102 (2009).
  • Mattiucci GC, Morganti AG, Valentini V et al. External beam radiotherapy plus 24-hour continuous infusion of gemcitabine in unresectable pancreatic carcinoma: long-term results of a Phase II study. Int. J. Radiat. Oncol. Biol. Phys. 76(3), 831–838 (2010).
  • Chang DT, Schellenberg D, Shen J et al. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer 115(3), 665–672 (2009).
  • Schellenberg D, Kim J, Christman-Skieller C et al. Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 81(1), 181–188 (2011).
  • Young RF. The role of the gamma knife in the treatment of malignant primary and metastatic brain tumors. CA. Cancer J. Clin. 48(3), 177–188 (1998).
  • Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L. Stereotactic body radiation therapy in multiple organ sites. J. Clin. Oncol. 25(8), 947–952 (2007).
  • Lo SS, Fakiris AJ, Chang EL et al. Stereotactic body radiation therapy: a novel treatment modality. Nat. Rev. Clin. Oncol. 7(1), 44–54 (2010).
  • Goyal K, Einstein D, Yao M et al. CyberKnife stereotactic body radiation therapy for nonresectable tumors of the liver: preliminary results. HPB Surg. 2010, 309780 (2010).
  • Park C, Papiez L, Zhang S, Story M, Timmerman RD. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 70(3), 847–852 (2008).
  • Wang JZ, Huang Z, Lo SS, Yuh WT, Mayr NA. A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy. Sci. Transl. Med. 2(39), 39ra48 (2010).
  • Ceha HM, van Tienhoven G, Gouma DJ et al. Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma. Cancer 89(11), 2222–2229 (2000).
  • Sanders MK, Moser AJ, Khalid A et al. EUS-guided fiducial placement for stereotactic body radiotherapy in locally advanced and recurrent pancreatic cancer. Gastrointest. Endosc. 71(7), 1178–1184 (2010).
  • Seo Y, Kim MS, Yoo S et al. Stereotactic body radiation therapy boost in locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 75(5), 1456–1461 (2009).
  • Goyal K, Einstein D, Ibarra RA et al. Stereotactic body radiation therapy for nonresectable tumors of the pancreas. J. Surg. Res. 174(2), 319–325 (2012).
  • Chang BK, Timmerman RD. Stereotactic body radiation therapy: a comprehensive review. Am. J. Clin. Oncol. 30(6), 637–644 (2007).
  • Grote T, Logsdon CD. Progress on molecular markers of pancreatic cancer. Curr. Opin. Gastroenterol. 23(5), 508–514 (2007).
  • Yu C, Main W, Taylor D, Kuduvalli G, Apuzzo ML, Adler JR Jr. An anthropomorphic phantom study of the accuracy of CyberKnife spinal radiosurgery. Neurosurgery 55(5), 1138–1149 (2004).
  • Koong AC, Christofferson E, Le QT et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Int. J. Radiat. Oncol. Biol. Phys. 63(2), 320–323 (2005).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.